Cannabis Sativa, Inc. Announces Signing of Business Consulting Agreement
January 06 2015 - 2:31AM
Business Wire
Cannabis Sativa, Inc. (OTCQB:CBDS) (referred to collectively
with its subsidiaries as “CBDS”) today announced that it has signed
a consulting agreement with consultants Jeff W. Holmes, Greg W.
Holmes and Kevin J. Asher. Under the terms of the agreement the
consultants will assist Cannabis Sativa, Inc. to build a
comprehensive financial business model, develop and structure
financial instruments to assist the company in capital raises and
help prepare Cannabis Sativa, Inc. for the filing and application
process for the NASDAQ markets, among other services.
“We are excited to work with Cannabis Sativa, Inc. which has an
exemplary management team and board of directors,” said Jeff W.
Holmes. “We believe in the legitimacy and market growth potential
of the marijuana industry and we have identified Cannabis Sativa,
Inc. as a company we believe to be well positioned in the cannabis
market.”
“With the signing of the consulting agreement we are committed
to move the company to the next level and execute on our business
plan,” said former New Mexico governor Gary Johnson, CEO of
Cannabis Sativa, Inc. “Further Jeff Holmes, Greg Holmes and Kevin
Asher have extensive experience working with public companies and
they can assist us with our strategic planning, development and
guidance that we need as a public company.”
About CBDS
Cannabis Sativa, Inc. is engaged through its recently acquired
subsidiary, Kush, in the research, development and licensing of
specialized natural cannabis products, including cannabis formulas,
edibles, topicals, strains, recipes and delivery systems. CBDS also
offers the Skin Garden line of cosmetic products through its
subsidiary, Wild Earth Naturals, which are designed to use organic
and natural ingredients, including hemp seed oil, to benefit inner
wellbeing as well as outward appearance.
Forward-Looking Statements
This press release contains “forward-looking statements.”
Although the forward-looking statements in this release reflect the
good faith judgment of management, forward-looking statements are
inherently subject to known and unknown risks and uncertainties
that may cause actual results to be materially different from those
discussed in these forward-looking statements. Readers are urged to
carefully review and consider the various disclosures made by us in
our reports filed with the Securities and Exchange Commission,
including the risk factors that attempt to advise interested
parties of the risks that may affect our business, financial
condition, results of operation and cash flows. If one or more of
these risks or uncertainties materialize, or if the underlying
assumptions prove incorrect, our actual results may vary materially
from those expected or projected. Readers are urged not to place
undue reliance on these forward-looking statements, which speak
only as of the date of this release. We assume no obligation to
update any forward-looking statements in order to reflect any event
or circumstance that may arise after the date of this release.
Cannabis Sativa, Inc.Media Contact:Michael Pickens,
209-402-7440michaelpickens@CBDS.comorInvestor
Information:702-345-4074
Cannabis Sativa (QB) (USOTC:CBDS)
Historical Stock Chart
From May 2024 to Jun 2024
Cannabis Sativa (QB) (USOTC:CBDS)
Historical Stock Chart
From Jun 2023 to Jun 2024